查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1279870

2023-2030年全球CAR T细胞疗法市场规模研究与预测，按适应症、药物类型、终端用户和区域分析。

Global CAR T-Cell therapy Market Size study & Forecast, by Indication, By Drug Type, By End user, and Regional Analysis, 2023-2030
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2022年全球CAR T细胞疗法市场价值约为19.3亿美元，预计在2023-2030年预测期内将以超过13.5%的健康增长率增长。嵌合抗原受体（CAR）T细胞疗法是一种新型的癌症疗法，医学专家在实验室里对T细胞进行改造，然后再将其注射到癌症患者的体内，使其能够检测和消除癌细胞。通过CAR T细胞疗法，免疫系统被训练为识别恶性细胞。通过CAR T细胞治疗，针对恶性细胞的免疫反应得到了增强。驱动CAR T细胞疗法市场的主要因素是对治疗癌症的合适疗法的需求增加，一些国家对CAR T细胞疗法药物的有利报销政策，以及消费者对CAR T细胞疗法药物的认识增加。此外，最近CAR-T细胞疗法的商业化和临床试验活动的激增，也进一步影响了市场的扩张。

此外，白血病和淋巴瘤等癌症发病率的增加也直接增加了对CAR T细胞疗法的需求。根据世界卫生组织（WHO）的数据，2020年，白血病癌症病例估计为47.5万，预计到2040年将达到69.2万患者。因此，癌症发病率的增长正在推动对广泛的诊断和治疗方案的需求，这反过来又加速了CAR T细胞疗法市场的增长。此外，在研究和开发方面的投资不断增加，以及技术的不断进步，在预测的几年里呈现出各种有利可图的机会。然而，在2023-2030年的预测期内，缺乏熟练的专业人员和开发CAR T细胞疗法的高成本正在挑战市场增长。

全球CAR T细胞疗法市场研究考虑的主要地区包括亚太、北美、欧洲、拉美、中东和非洲。北美在2022年占据了市场的主导地位，这是因为监管部门的批准不断增加，对先进的医疗设施的投资不断增加，以及技术发展不断上升。而亚太地区预计将在预测的几年里以最高的复合年增长率增长。癌症发病率的上升，政府机构对新型疗法研究资金的增加，以及对新型药物的认识和批准的增加，都大大推动了整个地区的市场需求。

该研究的目的是确定近年来不同领域和国家的市场规模，并预测未来几年的价值。该报告旨在将研究涉及的国家内的行业的定性和定量方面都纳入其中。

该报告还提供了关于关键方面的详细信息，如驱动因素和挑战，这将确定市场的未来增长。此外，它还纳入了微观市场的潜在机会，供利益相关者投资，并详细分析了竞争格局和主要参与者的产品。.

目录

第一章：执行摘要

  • 市场简介
  • 2020-2030年全球及细分市场的估计和预测
    • 2020-2030年CAR T细胞治疗市场，按地区划分
    • 2020-2030年，CAR T细胞疗法市场，按适应症划分
    • 2020-2030年，CAR T细胞疗法市场，按药物类型划分
    • 2020-2030年，CAR T细胞疗法市场，按终端用户划分
  • 主要趋势
  • 估算方法
  • 研究假设

第二章：全球CAR T细胞疗法市场的定义和范围

  • 本研究的目的
  • 市场定义和范围
    • 行业演变
    • 研究的范围
  • 研究考虑的年份
  • 货币转换率

第三章：全球CAR T-细胞疗法市场动态

  • CAR T细胞疗法的市场影响分析（2020-2030）。
    • 市场驱动力
      • 白血病和淋巴瘤等癌症的发病率增加
      • 对CAR T细胞疗法药物的有利报销政策
    • 市场挑战
      • 无法获得熟练的专业人员
      • 开发CAR T细胞疗法的成本高
    • 市场机会
      • 研究和开发的投资不断增加
      • 技术的不断进步

第四章：全球CAR T细胞疗法市场行业分析

  • 波特的5力模型
    • 供应商的议价能力
    • 买方的讨价还价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争性的竞争
  • 波特五力影响分析
  • PEST分析
    • 政治
    • 经济
    • 社会
    • 技术
    • 环境
    • 法律问题
  • 最佳投资机会
  • 最佳策略
  • COVID-19影响分析
  • 颠覆性趋势
  • 行业专家的观点
  • 分析师建议与结论

第五章：全球CAR T细胞治疗市场，按适应症分类

  • 市场简介
  • 全球CAR T细胞疗法市场，按适应症、性能 - 潜力分析
  • 2020-2030年全球CAR T细胞治疗市场按适应症的估计和预测
  • CAR T细胞疗法市场，細項分析
    • 淋巴瘤
    • 急性淋巴细胞白血病
    • 其他疾病

第六章：全球CAR T细胞疗法市场，按药物类型划分

  • 市场简介
  • 全球CAR T细胞疗法市场，按药物类型，性能-潜力分析
  • 2020-2030年全球CAR T细胞治疗市场按药物类型的估计和预测
  • CAR T细胞疗法市场，細項分析
    • Axicabtagene Ciloleucel
    • Tisagenlecleucel
    • Brexucabtagene Autoleucel
    • 其他

第7章 ：全球CAR T细胞治疗市场，按终端用户划分

  • 市场简介
  • 全球CAR T细胞疗法市场，按终端用户，性能-潜力分析
  • 2020-2030年全球CAR T细胞治疗市场按终端用户的估计和预测
  • CAR T-细胞疗法市场，細項分析
    • 医院
    • 癌症治疗中心

第八章：全球CAR T-细胞疗法市场，区域分析

  • 最领先的国家
  • 新兴国家
  • CAR T细胞疗法市场，区域市场简介
  • 北美洲
    • 美国
      • 适应症分类估计和预测，2020-2030年
      • 2020-2030年药物类型分类估计和预测
      • 2020-2030年终端用户分类估计和预测
    • 加拿大
  • 欧洲CAR T细胞疗法市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 亚太地区CAR T细胞治疗市场简介
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 亚太其他地区
  • 拉丁美洲CAR T细胞疗法市场概况
    • 巴西
    • 墨西哥
  • 中东和非洲
    • 沙特阿拉伯
    • 南非
    • 中东和非洲其他地区

第九章：竞争情报

  • 主要公司SWOT分析
    • 公司1
    • 公司二
    • 公司3
  • 顶级市场战略
  • 公司简介
    • Autolus Therapeutics
      • 关键信息
      • 概况
      • 财务（取决于数据的可用性）
      • 产品摘要
      • 近期发展情况
    • Bluebird bio, Inc.
    • Bristol-Myers Squibb
    • Caribou Biosciences, Inc.
    • Cartesian Therapeutics, Inc.
    • Celgene Corporation
    • Gilead Sciences, Inc. (Kite Pharma Inc.)
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer, Inc.

第十章 ：研究过程

  • 研究过程
    • 资料探勘
    • 数据分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
  • 研究假设

Global CAR T-Cell therapy Market is valued at approximately USD 1.93 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 13.5% over the forecast period 2023-2030. Chimeric antigen receptor (CAR) T cell therapy is a novel form of cancer therapy in which medical experts modify T cells in a lab before injecting them into cancer patients' bodies to enable them to detect and eliminate cancer cells. The immune system is trained to recognize malignant cells by CAR T-cell therapy. The immune response against malignant cells is boosted by CAR T-cell treatment. The market for CAR T-cell therapy is primarily driven by an increase in the demand for suitable therapeutics for the treatment of cancer, favorable reimbursement policies for CAR T-cell therapy medications in some countries, and an increase in consumer awareness of CAR T-cell therapy medications. Additionally, the recent commercialization of CAR-T cell therapy and the surging clinical trial activities are further influencing the market expansion.

In addition, an increase in the incidence of cancer such as leukemia and lymphoma are directly augmenting the demand for CAR T-Cell therapy. According to World Health Organization (WHO), in 2020, the number of leukemia cancer cases is estimated to account for 475 thousand, which is projected to reach 692 thousand patients by the year 2040. Accordingly, the growing prevalence of cancer is fueling the demand for a wide range of diagnosis and treatment alternatives, which, in turn, accelerates the growth of the CAR T-Cell therapy Market. Moreover, the growing investment in research and development, as well as increasing advancements in technology present various lucrative opportunities over the forecasting years. However, the unavailability of skilled professionals and the high cost of developing CAR T-cell therapy are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global CAR T-Cell therapy Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing regulatory approvals, growing investment in advancing healthcare facilities, and rising technological developments. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rising prevalence of cancer, increasing research funding for novel therapeutics by government bodies, and growing awareness and increase in approval of novel medications are significantly propelling the market demand across the region.

Major market players included in this report are:

  • Autolus Therapeutics
  • Bluebird bio, Inc.
  • Bristol-Myers Squibb
  • Caribou Biosciences, Inc.
  • Cartesian Therapeutics, Inc.
  • Celgene Corporation
  • Gilead Sciences, Inc. (Kite Pharma Inc.)
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.

Recent Developments in the Market:

  • In June 2022, Bristol-Myers Squibb Company announced that the company received the U.S. Food and Drug Administration (FDA) approval for Breyanzi CAR T cell therapy to cure refractory or relapsed large B-cell lymphoma after one prior therapy. The Phase 2 pilot company-sponsored research of a CAR T cell treatment in patients with primary refractory or relapsed LBCL served as the foundation for the approval.
  • In February 2022, Johnson & Johnson Services, Inc. declared that the U.S. Food and Drug Administration had approved CARVYKTI (ciltacabtagene autoleucel), a BCMA-Directed CAR-T Immunotherapy for the treatment of Patients with Relapsed or Refractory Multiple Myeloma.

Global CAR T-Cell therapy Market Report Scope:

  • Historical Data: - 2020 - 2021
  • Base Year for Estimation: - 2022
  • Forecast period: - 2023-2030
  • Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: - Indication, Drug type, End user, Region
  • Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Indication:

  • Lymphoma
  • Acute Lymphocytic Leukemia
  • Others

By Drug type:

  • Axicabtagene Ciloleucel
  • Tisagenlecleucel
  • Brexucabtagene Autoleucel
  • Others

By End-user:

  • Hospitals
  • Cancer Treatment Centers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. CAR T-Cell therapy Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. CAR T-Cell therapy Market, by Indication, 2020-2030 (USD Billion)
    • 1.2.3. CAR T-Cell therapy Market, by Drug type, 2020-2030 (USD Billion)
    • 1.2.4. CAR T-Cell therapy Market, by End user, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global CAR T-Cell therapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global CAR T-Cell therapy Market Dynamics

  • 3.1. CAR T-Cell therapy Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in the incidence of cancer such as leukemia and lymphoma
      • 3.1.1.2. Favorable reimbursement policies for CAR T-cell therapy medications
    • 3.1.2. Market Challenges
      • 3.1.2.1. Unavailability of skilled professionals
      • 3.1.2.2. High cost of developing CAR T-cell therapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Growing investment in research and development
      • 3.1.3.2. Increasing advancements in technology

Chapter 4. Global CAR T-Cell therapy Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global CAR T-Cell therapy Market, by Indication

  • 5.1. Market Snapshot
  • 5.2. Global CAR T-Cell therapy Market by Indication, Performance - Potential Analysis
  • 5.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Indication 2020-2030 (USD Billion)
  • 5.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 5.4.1. Lymphoma
    • 5.4.2. Acute Lymphocytic Leukemia
    • 5.4.3. Others

Chapter 6. Global CAR T-Cell therapy Market, by Drug type

  • 6.1. Market Snapshot
  • 6.2. Global CAR T-Cell therapy Market by Drug type, Performance - Potential Analysis
  • 6.3. Global CAR T-Cell therapy Market Estimates & Forecasts by Drug type 2020-2030 (USD Billion)
  • 6.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 6.4.1. Axicabtagene Ciloleucel
    • 6.4.2. Tisagenlecleucel
    • 6.4.3. Brexucabtagene Autoleucel
    • 6.4.4. Others

Chapter 7. Global CAR T-Cell therapy Market, by End user

  • 7.1. Market Snapshot
  • 7.2. Global CAR T-Cell therapy Market by End user, Performance - Potential Analysis
  • 7.3. Global CAR T-Cell therapy Market Estimates & Forecasts by End user 2020-2030 (USD Billion)
  • 7.4. CAR T-Cell therapy Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Cancer Treatment Centers

Chapter 8. Global CAR T-Cell therapy Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. CAR T-Cell therapy Market, Regional Market Snapshot
  • 8.4. North America CAR T-Cell therapy Market
    • 8.4.1. U.S. CAR T-Cell therapy Market
      • 8.4.1.1. Indication breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Drug type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End user breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada CAR T-Cell therapy Market
  • 8.5. Europe CAR T-Cell therapy Market Snapshot
    • 8.5.1. U.K. CAR T-Cell therapy Market
    • 8.5.2. Germany CAR T-Cell therapy Market
    • 8.5.3. France CAR T-Cell therapy Market
    • 8.5.4. Spain CAR T-Cell therapy Market
    • 8.5.5. Italy CAR T-Cell therapy Market
    • 8.5.6. Rest of Europe CAR T-Cell therapy Market
  • 8.6. Asia-Pacific CAR T-Cell therapy Market Snapshot
    • 8.6.1. China CAR T-Cell therapy Market
    • 8.6.2. India CAR T-Cell therapy Market
    • 8.6.3. Japan CAR T-Cell therapy Market
    • 8.6.4. Australia CAR T-Cell therapy Market
    • 8.6.5. South Korea CAR T-Cell therapy Market
    • 8.6.6. Rest of Asia Pacific CAR T-Cell therapy Market
  • 8.7. Latin America CAR T-Cell therapy Market Snapshot
    • 8.7.1. Brazil CAR T-Cell therapy Market
    • 8.7.2. Mexico CAR T-Cell therapy Market
  • 8.8. Middle East & Africa CAR T-Cell therapy Market
    • 8.8.1. Saudi Arabia CAR T-Cell therapy Market
    • 8.8.2. South Africa CAR T-Cell therapy Market
    • 8.8.3. Rest of Middle East & Africa CAR T-Cell therapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Autolus Therapeutics
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Bluebird bio, Inc.
    • 9.3.3. Bristol-Myers Squibb
    • 9.3.4. Caribou Biosciences, Inc.
    • 9.3.5. Cartesian Therapeutics, Inc.
    • 9.3.6. Celgene Corporation
    • 9.3.7. Gilead Sciences, Inc. (Kite Pharma Inc.)
    • 9.3.8. Merck & Co., Inc.
    • 9.3.9. Novartis AG
    • 9.3.10. Pfizer, Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global CAR T-Cell therapy Market, report scope
  • TABLE 2. Global CAR T-Cell therapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global CAR T-Cell therapy Market estimates & forecasts by Indication 2020-2030 (USD Billion)
  • TABLE 4. Global CAR T-Cell therapy Market estimates & forecasts by Drug type 2020-2030 (USD Billion)
  • TABLE 5. Global CAR T-Cell therapy Market estimates & forecasts by End user 2020-2030 (USD Billion)
  • TABLE 6. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global CAR T-Cell therapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global CAR T-Cell therapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia CAR T-Cell therapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA CAR T-Cell therapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global CAR T-Cell therapy Market
  • TABLE 71. List of primary sources, used in the study of global CAR T-Cell therapy Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global CAR T-Cell therapy Market, research methodology
  • FIG 2. Global CAR T-Cell therapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global CAR T-Cell therapy Market, key trends 2022
  • FIG 5. Global CAR T-Cell therapy Market, growth prospects 2023-2030
  • FIG 6. Global CAR T-Cell therapy Market, porters 5 force model
  • FIG 7. Global CAR T-Cell therapy Market, pest analysis
  • FIG 8. Global CAR T-Cell therapy Market, value chain analysis
  • FIG 9. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global CAR T-Cell therapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global CAR T-Cell therapy Market, regional snapshot 2020 & 2030
  • FIG 15. North America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America CAR T-Cell therapy Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa CAR T-Cell therapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable